Farms.com Home   News

Cattle futures dip, pork exports surge - U.S. Livestock market update

By Farms.com

In recent trading sessions, Chicago Mercantile Exchange (CME) cattle futures saw a decline, extending for the third consecutive session. Concerns over future beef demand weighed on prices, with technical trading pushing the most-active August live cattle contract to a two-week low.

The downturn in cattle prices was also attributed to shifts by hedge funds, who adjusted their positions ahead of the summer months, leading to profit-taking at month's end. Additionally, the increased weight of slaughter-ready animals compared to last year added pressure on futures prices.

As boxed beef cutout prices decreased, market participants questioned the potential summer demand for U.S. beef. The choice boxed beef cutout value eased down to $313.20 per hundredweight, reflecting broader concerns about market stability and peak pricing.

Conversely, lean hog futures experienced an uptick driven by a surge in weekly U.S. pork exports. Traders noted discussions in the market regarding overselling of hog futures and observed stability in pork cutout prices.

The most-active CME July hog futures ended higher, while August live cattle futures closed lower. June live cattle and August feeder cattle futures also settled down, marking mixed performance across livestock segments.

These developments underscore the dynamic nature of the U.S. livestock market, influenced by factors such as demand fluctuations, trade dynamics, and investor sentiment.

Market participants continue to monitor these trends closely to navigate market uncertainties and capitalize on emerging opportunities.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.